Bright Minds Begins Phase 1 Clinical Trials Focused On Treating Dravet Syndrome
Phase 1 trials are officially underway for Bright Minds Biosciences (CSE: DRUG) and their lead product, referred to as BMB-101.
Read more
Psychedelics
Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance
Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The psychedelic firm late on Friday
Read more
Mind Medicine Begins Phase 2B Study On Treating Generalized Anxiety Disorder With LSD Variant
Mind Medicine (NEO: MMED) has officially seen patient trials under a Phase 2b study get underway as it looks to
Read more
20-Year-Old Makes $110 Million From Bed Bath & Beyond Stock.. Next Stop: MindMed
20-year-old Jake Freeman just walked away with around $110 million from selling his 6.21% stake in meme-stock favorite Bed Bath
Read more
MindMed Declares US$17.0 Million Net Loss, US$105.7 Million Cash Balance For Q2 2022
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday its financial results for Q2 2022. The
Read more
Mind Medicine Sees Co-Founder Become An Activist Shareholder Demanding Changes
An activist shareholder battle might be brewing at Mind Medicine (NEO: MMED). This morning, co-founder of the company Dr Scott
Read more
Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq Listing Requirements
In a classic Canadian small cap move, Mind Medicine (NEO: MMED) last night announced that it’s directors have approved a
Read more
Mind Medicine To Raise Up To $100 Million Via ATM Financing
Mind Medicine (NEO: MMED) last night announced that it will be conducting a financing. The company is looking to raise
Read more
Field Trip Health To Divide Into Two Separate Firms
Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The company last night indicated that
Read more
Mydecine Announces 50 To 1 Share Consolidation
Mydecine Innovations (NEO: MYCO) is the latest firm to announce a reverse stock split amid a recent trend amongst small
Read more